Vivere Oncotherapies

Background

Vivere Oncotherapies

David Schaffer (image soon), Founder & CEO of Vivere Oncotherapies

Vivere Oncotherapies is a spin-out from the labs of David Schaffer and John Dueber at UC Berkeley.

Vivere Oncotherapies is advancing personalized medicine using directed evolution to create highly specific and effective vectors and genetic cargoes to cure cancers of unmet need.

Co-investors

None

University Spinout

UC Berkeley